Bibliographic record and links to related information available from the Library of Congress catalog.
Note: Contents data are machine generated based on pre-publication provided by the publisher. Contents may have variations from the printed book or be incomplete or contain other coding.
Foreword ¿ Piotr Grodzinski, Section I. Nanotechnology and Cancer Chapter 1. Introduction and Rationale for Nanotechnology in Cancer Therapy. F. Robertson and M. Ferrari. Chapter 2. Passive Targeting of Solid Tumors: Pathophysiological Principles and Physicochemical Aspects of Delivery Systems. S.M. Moghimi. Chapter 3. Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications Chapter 4. Pharmacokinetic Analysis of Nanocarrier-Mediated Drug and Gene Delivery. Y. Higuchi, S. Kawakami, and M. Hashida Chapter 5. Multifunctional Nanoparticles for Cancer Therapy. T.J. Harris, G. von Maltzahn, S.N. Bhatia Chapter 6. Neutron Capture Therapy of Cancer: Nanoparticles and High Molecular Weight Boron Delivery Agents. G. Wu, R.F. Barth, W. Yang, R. Lee, W. Tjarks, M.V. Backer, and J.M. Backer. Chapter 7. Preclinical Characterization of Engineered Nanoparticles Intended for Cancer Therapeutics. A. Patri, M. Dobrovolskaia, S. Stern, and S. McNeil. Chapter 8. Nanotechnology: Regulatory Perspective for Drug Development in Cancer Therapeutics. N. Sadrieh and T.J. Miller Section II. Polymer Conjugates Chapter 9. Polymeric Conjugates for Angiogenesis Targeted Tumor Imaging and Therapy. A. Mitra, A. Nan, B.R. Line, and H. Ghandehari. Chapter 10. Poly(L-glutamic acid): Efficient Carrier of Cancer Therapeutics and Diagnostics. G. Zhang, E. Jackson, S. Wallace, and C. Li. Chapter 11. Non-Invasive Visualization of In Vivo Drug Delivery of Paramagnetic Polymer Conjugates with MRI . Z.-R. Lu, Y. Wang, F. Ye, A. Vaidya and E.-K. Jeong Section III. Polymeric Nanoparticles Chapter 12. Polymeric Nanoparticles for Tumor-Targeted Drug Delivery. T. Betancourt, A. Doiron, and L. Brannon-Peppas. Chapter 13. Long-circulating Polymeric Nanocarriers for Drug and Gene Delivery to Tumors. S. Kommareddy, D.B. Shenoy, and M.M. Amiji Chapter 14. Biodegradable PLGA/PLA Nanoparticles for Anticancer Therapy. S. K. Sahoo and V. Labhasetwar. Chapter 15. Poly(alkyl cyanoacrylate) Nanoparticles for Delivery of Anticancer Drugs. R.S.R. Murthy and L. Harivardan Reddy. Chapter 16. Aptamers and Cancer Nanotechnology. O.C. Farokhzad, S. Jon, and R. Langer. Section IV. Polymeric Micelles Chapter 17. Polymeric Micelles for Formulation of Anticancer Drugs. H. Lee, P.-L. Soo, J. Liu, M. Butler, and C. Allen Chapter 18. PEO-Modified Poly(L-amino acid) Micelles for Drug Delivery. A. Lavasanifar, X.-B. Xiong, H.M. Aliabadi Chapter 19. Hydrotropic Polymer Micellar for Cancer Therapeutics. S. C. Lee, K. M. Huh, T. Ooya, and K. Park Chapter 20. Tumor-targeted delivery of sparingly-soluble anticancer drugs with polymeric lipid-core immunomicelles. V.P. Torchilin. Chapter 21. Combined Cancer Therapy by Micellar-Encapsulated Drug and Ultrasound. N. Rapoport Chapter 22. Polymeric Micelles for Targeting Tumor pH. E.S. Lee and Y.H. Bae. Chapter 23. cRGD-Encoded, MRI-Visible Polymeric Micelles for Tumor-Targeted Drug Delivery. J. Gao, N. Nasongkla, and C. Khemtong Chapter 24. Targeted Antisense Oligonucleotide Micellar Delivery Systems. J.H. Jeong, S.H. Kim, T.G. Park Section V. Dendritic Nanocarriers Chapter 25. Dendrimers in Drug and Gene Delivery. T. Kim and J.-S. Park Chapter 26. Dendritic Nanostructures for Cancer Therapy. A.V. Ambade, E. N. Savariar, and S. Thayumanavan Chapter 27. PEGylated Dendritic Nanoparticulate Carriers of Anticancer Drug. D. Bhadra, S. Bhadra, and N.K. Jain Chapter 28. Dendrimer Nanocomposites for Cancer Therapy. L.P. Balogh and M.K. Khan. Section VI. Liposomes Chapter 29. Applications of Liposomal Drug Delivery Systems to Cancer Therapy. A. Gabizon Chapter 30. Positively-Charged Liposomes for Targeting Tumor Vasculature Chapter 31. Cell Penetrating Peptide (CPP)-Modified Liposomal Nanocarriers for Intracellular Drug and Gene Delivery. V.P. Torchilin. Chapter 32. RGD-Modified Liposomes for Tumor Targeting. S.P. Vyas Chapter 33. Folate Receptor-Targeted Liposomes for Cancer Therapy. X.B. Zhao, N. Muthusamy, J.C. Byrd, R.J. Lee. Chapter 34. Nanoscale Drug Delivery Vehicles for Solid Tumors: A New Paradigm for Localized Drug Delivery Using Temperature Sensitive Liposomes. D. Needham and A. Ponce. Section VII. Other Lipid Nanostructures Chapter 35. Nanoemulsions for Tumor Targeted Delivery. S. Tiwari and M. Amiji Chapter 36. Solid-Lipid Nanoparticles for Antitumor Drug Delivery. H. L. Wong, Y. Li, R. Bendayan, M. A. Rauth, and X. Y. Wu* Chapter 37. Lipoprotein Nanoparticles as Delivery Vehicles for Anti-cancer Therapy. A.G. Lacko, M. Nair, and W.J. McConathy Chapter 38. DQAsomes as Mitochondria-Targeted Nano-Carriers for Anticancer Drugs. S.-M. Cheng, S.V. Boddapati, G.G.M. D¿Souza and V. Weissig Index
Library of Congress Subject Headings for this publication:
Cancer.
Nanotechnology.
Drug targeting.
Antineoplastic agents.
Neoplasms -- therapy.
Drug Delivery Systems.
Nanotechnology.
Neoplasms -- diagnosis.